More than 20% of people living in post-conflict settings have a mood disorder, anxiety, or post-traumatic stress disorder. | Continue reading
A monthly subcutaneous injection of RBP-600 was found to be well-tolerated and effective for promoting abstinence in patients with moderate to severe opioid use disorder. | Continue reading